The signing ceremony of the cooperation between Runde Biology and Lushang Freda Pharmaceutical Group was successfully held
2022-05-20 11:23
On November 12, the signing ceremony of Shandong Runde Biotechnology Co., Ltd. and Lushang Group Shandong Freda Pharmaceutical Group Co., Ltd. was successfully held. Gao Honglei, Secretary of the Party Committee and Chairman of Lushang Group and Chairman of Guoxin Cultural Tourism, Liu Shouliang, Deputy Secretary of the Party Committee of Lushang Group, Ge Jian, Chairman of Lushang Health Industry Development Co., Ltd., and Jia Qingwen, Chairman of Shandong Freda Pharmaceutical Group Co., Ltd. Relevant persons in charge; Secretary of Xintai Municipal Party Committee Liu Qinhai, Mayor Song Hongpeng, Deputy Secretary of Xintai Municipal Party Committee Sang Min, Deputy Director of Xintai Municipal Party Committee Deep Reform Committee, second-level inspector Ma Xiuyi, Xintai CPPCC Chairman Xia Nianxin, Xintai Municipal Committee Standing Committee Member, Xintai Municipal Committee Zhao Wenpo, Director of the Office, Jia Fujun, Deputy Mayor of Xintai Municipal Government, and Lu Wei, Chairman of Runde Biology attended the signing ceremony. Jia Qingwen and Lu Wei signed the cooperation agreement on behalf of both parties.
Lu Wei introduced the relevant situation of Runde Biology in his speech. He said that Runde Bio is a national high-tech enterprise and a national manufacturing single champion demonstration enterprise focusing on the research and development, production, marketing, international trade and technical services of biological products. The company's main glucosamine (referred to as glucosamine) series products are important raw materials for the production of products with efficacy in preventing and treating bone and joint diseases, enhancing immunity, anti-oxidation, and anti-aging. They can be widely used in medicine, health care products, food, Cosmetics, feed, fertilizer and other fields. The glucosamine raw material produced by Runde Bio has a global market share of more than 50%, and has strong advantages in technology research and development and device production capacity; Shandong Freda Pharmaceutical Group has product development and market development in the fields of orthopedic drugs, health products and cosmetics. There are outstanding advantages in marketing, and the two sides have complementary advantages in cooperation, and have broad development prospects.
Liu Shouliang said that Freda Pharmaceuticals Group, as the founder and leader of China's hyaluronic acid industry, has always been a world leader in the production of hyaluronic acid raw materials; The pharmaceutical and beauty industries are well-known. Runde Bio's glucosamine products are important raw materials for the treatment and care of osteoarthritis, and have a very high degree of fit with Freda. Today's signing will closely combine Runde Bio's raw materials and technical advantages of glucosamine with the advantages of Freda's pharmaceuticals, health products, and cosmetics in the entire industry chain of R&D, production and sales. This powerful combination will surely create a world-class The leading enterprise of glucosamine raw materials will also promote the development of glucosamine industry in China and even in the world, benefiting human bone health. This signing of investment is not only an important measure for Lushang Group to implement transformation and development, but also a strategic choice for the two companies to complement each other's advantages and achieve win-win cooperation. Lushang Group will fully support the construction and operation of the project. Freda will strengthen cooperation with Runde Bio with a high sense of responsibility, mission and urgency to ensure high-level construction, high-efficiency operation, and high-efficiency presentation to ensure the smooth progress of the project.
Related News
I am proud! Lu Wei, Chairman of Runde Biology, was awarded the industry leading entrepreneur and was awarded the provincial commendation!
2022/03/16
Focusing on scientific and technological innovation to creat
Focusing on scientific and technological innovation to create a new situation in the work of key laboratories, the State Food and Drug Administration held a meeting on work exchange and promotion of key laboratories
2022/05/13
On February 7, the first day of work after the Spring Festival, the Shandong Province 2022 Work Mobilization Conference was held to commend outstanding entrepreneurs, industry leaders and outstanding entrepreneurs in Shandong Province.
2022/05/13
Shandong Province 2022 Work Mobilization Conference Held
At the beginning of the new year, spring is full of vitality and Vientiane is renewed. On the morning of February 7, the Shandong Province 2022 Work Mobilization Conference was held in Jinan.
2022/05/13
International Marketing Center
Contact phone number: 86-531-83239125
Email: sales@rundeglobal.com
website:www.rundeglobal.com
Address: Room 2605,Building 6,Greenland Center, No.25 Gongqingtuan Road, Shizhong District, Jinan ,Shandong, China
CONTACT US
Wechat/（WhatsApp):+86 13853892022 13255487562
Tommy: tommy@rundebio.com yanmi@rundeint.com
Address : No. 78 Runde Road, Economic Development Zone, Xintai City, Shandong Province
Copyright : Shandong Runde Biotechnology Co., Ltd. 鲁ICP备2022010206号-1 Powerby : 300.cn jinan Seo Tags
